BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights

BMY.RT

Overview Fund Trends Analyst Outlook Journalist POV

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

Buy

Hold

Sell

We haven’t received any recent analyst ratings for BMY.RT.

We couldn't find any ratings matching your filter criteria.